Epilepsy phenotype and developmental outcome in girls with mosaicism in X‐linked neurodevelopmental disorders
Epileptic Disorders · 2025
DOI: 10.1002/epd2.70058 ↗Kurz gefasst
Fallbericht in der Zeitschrift Epileptic Disorders, 2025. Verfasst von Evelina Carapancea und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neuroscience (IoNS), Université Catholique de Louvain, Brussels, Belgium. Hauptthemen laut MEDLINE: Mosaicism, Neurodevelopmental Disorders, Protein Serine-Threonine Kinases, Epilepsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
CDKL5 deficiency disorder (CDD) and SMC1A‐related epilepsy are X‐linked neurodevelopmental disorders characterized by early‐onset, mostly intractable epilepsy and severe intellectual disability. While recent advances in next‐generation sequencing improved diagnostic yields, detecting low‐frequency mosaicism remains challenging. We retrospectively analyzed the epilepsy and developmental phenotype of four female patients with mosaic CDKL5 or SMC1A variants. Clinical data, including seizure types, electroencephalographic findings, neurodevelopmental milestones, and genetic analyses, were reviewed. The two girls with CDKL5 mosaicism presented at 5 and 6 weeks with tonic seizures, rapidly developing hypermotor‐tonic‐spasms sequence seizures. Both achieved independent walking by age two and developed speech by 3 years. The two girls with SMC1A mosaicism presented clusters of focal impaired awareness, myoclonic, and tonic–clonic seizures at 19 and 20 months of age. They demonstrated milder intellectual disabilities, with one achieving normal speech and the other speaking over 100 words by age four. Both achieved independent walking, which is uncommon in germline patients. Girls with mosaic CDKL5 and SMC1A variants share the same epilepsy phenotype as the germline females but have milder intellectual and motor disabilities compared to germline patients. Recognizing specific seizure patterns may direct genetic testing, enabling earlier diagnosis and access to precision treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Neuroscience (IoNS), Université Catholique de Louvain, Brussels, Belgium.
- Albert Einstein College of Medicine Saul R. Korey Department of Neurology, Laboratory of Developmental Epilepsy, Bronx, New York, USA.
- Isabelle Rapin Division of Child Neurology, Albert Einstein College of MedicineBronx, New York, USA.
- Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, USA.
- Division of Child Neurology, Department of Pediatrics, Cliniques Universitaires Saint-Luc, Institute of Neuroscience (IoNS), Université Catholique de Louvain, Brussels, Belgium.
- Department of Human Genetics, Institut de Pathologie et de Génétique, Charleroi, Belgium.
ORCID-Profile: Evelina Carapancea, Roberto Santalucia, Damien Lederer, Lieven Lagae, Solomon L Moshe, Maria Roberta Cilio
Förderung
- NICHD NIH HHS
Zitieren
APA
Carapancea, E., Eizadkhah, D., Santalucia, R., Lederer, D., Arts, F. A., Lagae, L., Moshe, S. L., & Cilio, M. R. (2025). Epilepsy phenotype and developmental outcome in girls with mosaicism in X‐linked neurodevelopmental disorders. Epileptic Disorders. https://doi.org/10.1002/epd2.70058
Vancouver
Carapancea E, Eizadkhah D, Santalucia R, Lederer D, Arts FA, Lagae L, et al. Epilepsy phenotype and developmental outcome in girls with mosaicism in X‐linked neurodevelopmental disorders. Epileptic Disorders. 2025. doi:10.1002/epd2.70058
BibTeX
@article{Carapancea2025,
author = {Carapancea, Evelina and Eizadkhah, Donya and Santalucia, Roberto and Lederer, Damien and Arts, Florence A and Lagae, Lieven and Moshe, Solomon L and Cilio, Maria Roberta},
title = {Epilepsy phenotype and developmental outcome in girls with mosaicism in X‐linked neurodevelopmental disorders},
journal = {Epileptic Disorders},
year = {2025},
doi = {10.1002/epd2.70058}
}
EUVIMED